strategic collaboration

Hyperscale Data ($GPUS) partners with AGIBOT on robotic systems, forecasts Q1 2026 revenue of $43-45M with 72-80% YoY growth.

Oxford BioTherapeutics partners with Bristol Myers Squibb to develop T-cell engager therapies for solid tumors, marking third major pharma deal in a year.

Subsea 7 announces Q1 2026 earnings April 30, highlighting major Chevron contract and PETRONAS Suriname partnership signaling robust order momentum.

Subsea7 and SLB OneSubsea form strategic alliance with PETRONAS Suriname to develop offshore fields, targeting cost reduction and improved project delivery.

KULR Technology announces March 31, 2026 earnings call alongside strategic battery partnerships with Robinson Helicopter and Hylio for electric aerospace and agricultural drone applications.

Galapagos and Gilead plan to jointly develop an Ouro T cell engager for autoimmune diseases, splitting acquisition costs while Galapagos leads development and Gilead commercializes, freeing $500M in Galapagos cash.

Qnity Electronics partners with $NVIDIA on semiconductor materials research and invests $61.5M in Taiwan facility launching 2027, with shares rising 0.46%.

AMC Robotics and HIVE Digital Technologies partner to provide GPU AI compute infrastructure for developing and deploying AI-driven robotics solutions in security, logistics, and manufacturing.

AMC Robotics and HIVE Digital partner to leverage GPU-based AI infrastructure for robotics development, testing, and deployment across optimization and scalability applications.

Tempus AI expands multi-year partnership with Merck to develop AI-driven precision medicine biomarkers, though stock declined 1.56% amid broader market weakness.